Bio View

Bio View Financial Leverage

The Financial Leverage (Equity Multiplier) of Bio View (BIOV.TA) as of Oct 18, 2026 is 2.11. In the previous year, Financial Leverage (Equity Multiplier) was 1.47 — a change of 44.14% (higher).

Financial Leverage

2.11

YoY

44.14%

Last updated:

Financial Leverage (Equity Multiplier) of Bio View is 2025 2.11 . Financial Leverage (Equity Multiplier) of Bio View was 2024 1.47 . It decreases by 44.14% higher compared to the previous year.

The Bio View Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.47 ILS
Jan 1, 2019
1.48 ILS
Jan 1, 2020
1.35 ILS
Jan 1, 2021
1.47 ILS
Jan 1, 2022
1.48 ILS
Jan 1, 2023
1.54 ILS
Jan 1, 2024
1.47 ILS
Jan 1, 2025
2.11 ILS
The Bio View Financial Leverage history
YEARFinancial LeverageYoY
2.11+44.14%
1.47-4.64%
1.54+3.62%
1.48+0.64%
1.47+8.99%
1.35-8.80%
1.48+0.93%
1.47-0.77%
1.48+5.54%
1.40-3.43%
1.45-15.18%
1.71—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio View Stock analysis

What does Bio View do? Bio View Ltd, based in Rehovot, Israel, operates in the Health Care sector, specializing in the research, development, marketing, and sales of advanced imaging systems. The company manufactures and services the Duet workstation, an automated cell diagnostic system used in cytology, hematology, and pathology laboratories for detecting and analyzing abnormal cells. It also offers the ALLEGRO and ACCORD workstations for specialized applications in cancer diagnosis, minimal-residual disease monitoring, and FISH-based analyses in cytogenetics and oncology. Bio View is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio View stock

Financial Leverage (Equity Multiplier) of Bio View is 2.11 in 2025.

Financial Leverage (Equity Multiplier) of Bio View changed from 1.47 to 2.11, representing a 44.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Bio View since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Bio View with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Bio View

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Bio View